ClearBridge Investments’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $952M | Sell |
5,021,518
-139,159
| -3% | -$26.2M | 0.79% | 23 |
|
|
2026
Q1 | $1.02B | Buy |
5,160,677
+3,058,395
| +145% | +$590M | 0.89% | 21 |
|
|
2025
Q4 | $387M | Sell |
2,102,282
-253,747
| -11% | -$44.5M | 0.31% | 82 |
|
|
2025
Q3 | $362M | Buy |
2,356,029
+179,352
| +8% | +$27.1M | 0.27% | 94 |
|
|
2025
Q2 | $304M | Buy |
2,176,677
+432,386
| +25% | +$60.6M | 0.25% | 101 |
|
|
2025
Q1 | $256M | Buy |
1,744,291
+12,196
| +0.7% | +$1.76M | 0.22% | 106 |
|
|
2024
Q4 | $227M | Sell |
1,732,095
-59,541
| -3% | -$8.34M | 0.18% | 122 |
|
|
2024
Q3 | $279M | Buy |
1,791,636
+89,762
| +5% | +$14.5M | 0.22% | 108 |
|
|
2024
Q2 | $265M | Buy |
1,701,874
+93,005
| +6% | +$14M | 0.22% | 112 |
|
|
2024
Q1 | $218M | Sell |
1,608,869
-187,355
| -10% | -$24.8M | 0.17% | 133 |
|
|
2023
Q4 | $242M | Buy |
1,796,224
+975,796
| +119% | +$127M | 0.21% | 120 |
|
|
2023
Q3 | $111M | Buy |
820,428
+470,958
| +135% | +$64.3M | 0.11% | 200 |
|
|
2023
Q2 | $50M | Buy |
349,470
+12,929
| +4% | +$1.9M | 0.05% | 316 |
|
|
2023
Q1 | $46.7M | Buy |
336,541
+32,519
| +11% | +$4.38M | 0.04% | 326 |
|
|
2022
Q4 | $41.2M | Buy |
304,022
+129
| +0% | +$16.2K | 0.04% | 344 |
|
|
2022
Q3 | $33.3M | Buy |
+303,893
| New | +$38.6M | 0.03% | 366 |
|
|
2021
Q2 | – | Sell |
-3,148
| Closed | -$313K | – | 826 |
|
|
2021
Q1 | $313K | Sell |
3,148
-288
| -8% | -$29K | ﹤0.01% | 781 |
|
|
2020
Q4 | $344K | Hold |
3,436
| – | – | ﹤0.01% | 763 |
|
|
2020
Q3 | $377K | Sell |
3,436
-299
| -8% | -$33.3K | ﹤0.01% | 723 |
|
|
2020
Q2 | $395K | Buy |
3,735
+660
| +21% | +$68.2K | ﹤0.01% | 677 |
|
|
2020
Q1 | $275K | Sell |
3,075
-36
| -1% | -$3.39K | ﹤0.01% | 683 |
|
|
2019
Q4 | $313K | Hold |
3,111
| – | – | ﹤0.01% | 712 |
|
|
2019
Q3 | $277K | Sell |
3,111
-19
| -0.6% | -$1.65K | ﹤0.01% | 722 |
|
|
2019
Q2 | $258K | Sell |
3,130
-128,943
| -98% | -$10.1M | ﹤0.01% | 728 |
|
|
2019
Q1 | $10.7M | Sell |
132,073
-2,368
| -2% | -$187K | 0.01% | 522 |
|
|
2018
Q4 | $10.2M | Buy |
134,441
+2,756
| +2% | +$215K | 0.01% | 523 |
|
|
2018
Q3 | $10.4M | Sell |
131,685
-15,038
| -10% | -$1.14M | 0.01% | 542 |
|
|
2018
Q2 | $10.3M | Sell |
146,723
-7,352
| -5% | -$529K | 0.01% | 480 |
|
|
2018
Q1 | $10.8M | Sell |
154,075
-855
| -0.6% | -$59.2K | 0.01% | 463 |
|
|
2017
Q4 | $10.8M | Sell |
154,930
-10,592
| -6% | -$714K | 0.01% | 470 |
|
|
2017
Q3 | $11.2M | Sell |
165,522
-214,654
| -56% | -$13.6M | 0.01% | 475 |
|
|
2017
Q2 | $25.9M | Sell |
380,176
-36,321
| -9% | -$2.37M | 0.03% | 403 |
|
|
2017
Q1 | $25.9M | Sell |
416,497
-28,817
| -6% | -$1.68M | 0.03% | 389 |
|
|
2016
Q4 | $24.3M | Sell |
445,314
-2,306,846
| -84% | -$131M | 0.03% | 380 |
|
|
2016
Q3 | $181M | Buy |
2,752,160
+2,620,632
| +1,992% | +$171M | 0.2% | 124 |
|
|
2016
Q2 | $7.94M | Buy |
131,528
+44,246
| +51% | +$2.57M | 0.01% | 496 |
|
|
2016
Q1 | $4.92M | Sell |
87,282
-180,949
| -67% | -$10.9M | 0.01% | 533 |
|
|
2015
Q4 | $18.2M | Buy |
268,231
+4,434
| +2% | +$291K | 0.02% | 423 |
|
|
2015
Q3 | $16.8M | Sell |
263,797
-51,684
| -16% | -$3.4M | 0.02% | 430 |
|
|
2015
Q2 | $20.1M | Sell |
315,481
-148,425
| -32% | -$10.2M | 0.02% | 427 |
|
|
2015
Q1 | $31.7M | Buy |
463,906
+310,474
| +202% | +$21.6M | 0.03% | 367 |
|
|
2014
Q4 | $10.8M | Sell |
153,432
-219,401
| -59% | -$15.7M | 0.01% | 510 |
|
|
2014
Q3 | $26.6M | Sell |
372,833
-928
| -0.2% | -$67.9K | 0.03% | 399 |
|
|
2014
Q2 | $27.8M | Sell |
373,761
-287,982
| -44% | -$20.8M | 0.03% | 397 |
|
|
2014
Q1 | $42.9M | Sell |
661,743
-967,465
| -59% | -$62.5M | 0.05% | 304 |
|
|
2013
Q4 | $96.7M | Buy |
1,629,208
+8,419
| +0.5% | +$457K | 0.12% | 176 |
|
|
2013
Q3 | $84.2M | Buy |
1,620,789
+1,618,854
| +83,662% | +$81.3M | 0.12% | 177 |
|
|
2013
Q2 | $92K | Buy |
+1,935
| New | +$98.5K | ﹤0.01% | 856 |
|
Other funds holding AZN
EP
IA
ClearBridge Investments's AZN Position: Q2 2026 in Review
ClearBridge Investments reduced its AstraZeneca (AZN) stake by 2.7% in Q2 2026, selling an estimated $26.2M and leaving 5,021,518 shares worth $952M. The position accounts for 0.79% of the portfolio, ranked #23.
ClearBridge Investments first reported a position in AZN in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.02B in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- ClearBridge Investments held 5,021,518 shares of AstraZeneca worth $952M as of Q2 2026.
- ClearBridge Investments sold 139,159 AstraZeneca shares in Q2 2026, an estimated $26.2M.
- AstraZeneca made up 0.79% of ClearBridge Investments's portfolio in Q2 2026, its #23 holding.
- ClearBridge Investments first reported a position in AstraZeneca in Q2 2013 and has held it in 48 quarters since.
- ClearBridge Investments's AstraZeneca position peaked at $1.02B in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.